IRF4 and cancer: There were also gene sets related to cancer signaling pathways (MYC, STAT3, and CDH1) or genes moderately involved in cancer (IRF4, SOX4, and EZH2), as well as some associated with various aspects of cancer such as cell transformation, metastasis, and response to therapeutics (Table S7).